Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Purulent bullous epidermal necrolysis: A potential new clinical pattern of drug eruption.

Liu LF, Yan JL, Wang JY, Chen JS, Cai SQ, Lao LM, Zheng M.

Exp Ther Med. 2013 Apr;5(4):1040-1042. Epub 2013 Feb 1.

2.
3.

Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.

Lee HY, Chou D, Pang SM, Thirumoorthy T.

Int J Dermatol. 2010 May;49(5):507-12. doi: 10.1111/j.1365-4632.2010.04313.x.

PMID:
20534083
4.

Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Harr T, French LE.

Orphanet J Rare Dis. 2010 Dec 16;5:39. doi: 10.1186/1750-1172-5-39. Review.

5.

Valdecoxib-associated acute generalized exanthematous pustulosis.

Byerly FL, Nelson KC, Granko RP, Morrell DS, Cairns BA.

Burns. 2005 May;31(3):383-7.

PMID:
15774300
6.

Acute generalized exanthematous pustulosis: atypical presentations and outcomes.

Kostopoulos TC, Krishna SM, Brinster NK, Ortega-Loayza AG.

J Eur Acad Dermatol Venereol. 2015 Feb;29(2):209-14. doi: 10.1111/jdv.12721. Epub 2014 Sep 8. Review.

PMID:
25201706
7.

Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.

Wolkenstein P, Chosidow O, Fléchet ML, Robbiola O, Paul M, Dumé L, Revuz J, Roujeau JC.

Contact Dermatitis. 1996 Oct;35(4):234-6.

PMID:
8957644
8.

Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.

Harr T, French LE.

Med Clin North Am. 2010 Jul;94(4):727-42, x. doi: 10.1016/j.mcna.2010.04.004. Review.

PMID:
20609860
9.

[The major SCAR syndromes].

Piérard GE, Lesuisse M, Piérard-Franchimont C.

Rev Med Liege. 2017 Oct;72(10):444-447. French.

PMID:
29058836
10.

Clinical heterogeneity of drug hypersensitivity.

Roujeau JC.

Toxicology. 2005 Apr 15;209(2):123-9. Review.

PMID:
15767024
11.

Severe acute generalized exanthematous pustulosis with blistering mimicking toxic epidermal necrolysis, associated with a primary mumps infection.

Azib S, Florin V, Fourrier F, Delaporte E, Staumont-Sallé D.

Clin Exp Dermatol. 2014 Aug;39(6):723-5. doi: 10.1111/ced.12384. Epub 2014 Jul 1.

PMID:
24986490
12.

[Severe cutaneous adverse drug reactions. Clinical features and epidemiology ].

Mockenhaupt M.

Hautarzt. 2005 Jan;56(1):24-31. Review. German.

PMID:
15625600
13.

Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature.

Peermohamed S, Haber RM.

Arch Dermatol. 2011 Jun;147(6):697-701. doi: 10.1001/archdermatol.2011.147. Review.

PMID:
21690532
14.

Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?

Bouvresse S, Valeyrie-Allanore L, Ortonne N, Konstantinou MP, Kardaun SH, Bagot M, Wolkenstein P, Roujeau JC.

Orphanet J Rare Dis. 2012 Sep 25;7:72. doi: 10.1186/1750-1172-7-72.

15.

Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy.

Mockenhaupt M.

J Dtsch Dermatol Ges. 2009 Feb;7(2):142-60; quiz 161-2. doi: 10.1111/j.1610-0387.2008.06878.x. Review. English, German.

PMID:
19371237
16.

Acute generalized exanthematous pustulosis simulating Stevens-Johnson syndrome/toxic epidermal necrolysis associated with the use of vismodegib.

Moreno-Arrones OM, Carrillo-Gijon R, Sendagorta E, Rios-Buceta L.

JAAD Case Rep. 2018 Jan 16;4(2):123-125. doi: 10.1016/j.jdcr.2017.08.001. eCollection 2018 Mar. No abstract available.

17.

Widespread bullous fixed drug eruption mimicking toxic epidermal necrolysis.

Baird BJ, De Villez RL.

Int J Dermatol. 1988 Apr;27(3):170-4.

PMID:
3286546
18.

Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine.

Goh TK, Pang SM, Thirumoorthy T, Goh SG.

Singapore Med J. 2008 Jun;49(6):507-10.

19.

Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy.

Paulmann M, Mockenhaupt M.

J Dtsch Dermatol Ges. 2015 Jul;13(7):625-45. doi: 10.1111/ddg.12747. English, German.

PMID:
26110722
20.

Supplemental Content

Support Center